The Medical Device Contract Manufacturing Market has seen significant growth, reaching USD 69.75 billion in 2023 and projected to rise to USD 191.40 billion by 2032, with a CAGR of 11.89%. The industry benefits from rising healthcare spending, demand for precision devices, and the adoption of outsourcing for efficiency and innovation. Contract manufacturers are using automation, AI, and 3D printing to enhance production quality and reduce risks.

The United States is a key player in outsourced medical device production, driven by strong regulatory standards, specialized manufacturing preferences, and the need for high precision devices. Investments in robotics, microfabrication, and biologics support market growth and innovation in the country.

Segmentation analysis shows Class II medical devices leading the market in revenue share, while Class III devices are expected to experience the highest growth. Accessories manufacturing dominates, with device manufacturing set to grow due to OEMs outsourcing entire production. Cardiovascular devices lead in revenue share, while ophthalmic devices are projected for high growth.

In terms of end-use, OEMs generate the highest revenue share, while pharmaceutical & biopharmaceutical companies are expected to grow due to drug-device combination products. Asia Pacific leads in revenue share for medical device contract manufacturing, with North America expected to be the fastest-growing region. Recent acquisitions by Arterex and Sanner Group have strengthened capabilities in medical device development and manufacturing.

Exclusive sections of the report include insights on R&D trends, cost structures, strategic alliances, workforce metrics, and investment trends. These sections provide valuable information on innovation, pricing, market dominance, workforce skills, and investment opportunities in the medical device contract manufacturing industry. The Medical Device Contract Manufacturing Market Report projects a market size of USD 69.75 billion in 2023, increasing to USD 191.40 billion by 2032, with a CAGR of 11.89% from 2024 to 2032. Key segments include usage mode, product type, services, therapeutic area, and end use. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

For more information on the Medical Device Contract Manufacturing Market Report and to access complete details, visit https://www.snsinsider.com/reports/medical-device-contract-manufacturing-market-5958. For customization requests, contact [email protected]. SNS Insider is a leading global market research and consulting agency, providing clients with current market data, consumer insights, and opinions to make informed decisions in a changing business landscape.

Read more at GlobeNewswire: Medical Device Contract Manufacturing Market to Reach USD